Literature DB >> 23631840

Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.

Takuro Arimura1, Kenji Onoue, Yumiko Takahashi-Tanaka, Taisuke Ishikawa, Masayoshi Kuwahara, Mitsutoshi Setou, Shuji Shigenobu, Katsushi Yamaguchi, Anne T Bertrand, Noboru Machida, Kazumi Takayama, Masayuki Fukusato, Ryo Tanaka, Satoshi Somekawa, Tomoya Nakano, Yoshihisa Yamane, Keiji Kuba, Yumiko Imai, Yoshihiko Saito, Gisèle Bonne, Akinori Kimura.   

Abstract

AIMS: Dilated cardiomyopathy (DCM) is characterized by ventricular dilation associated with systolic dysfunction, which could be caused by mutations in lamina/C gene (LMNA). LMNA-linked DCM is severe in males in both human patients and a knock-in mouse model carrying a homozygous p.H222P mutation (LmnaH222P/H222P). The aim of this study was to investigate the molecular mechanisms underlying the gender difference of LMNA-linked DCM. METHODS AND
RESULTS: A whole-exome analysis of a multiplex family with DCM exhibiting the gender difference revealed a DCM-linked LMNA mutation, p.R225X. Immunohistochemical analyses of neonatal rat cardiomyocytes expressing mutant LMNA constructs and heart samples from the LMNA-linked DCM patients and LmnaH222P/H222P mice demonstrated a nuclear accumulation of androgen receptor (AR) and its co-activators, serum response factor, and four-and-a-half LIM protein-2. Role of sex hormones in the gender difference was investigated in vivo using the LmnaH222P/H222P mice, where male and female mice were castrated and ovariectomized, respectively, or treated with testosterone or an antagonist of AR. Examination of the mice by echocardiography, followed by the analyses of histological changes and gene/protein expression profiles in the hearts, confirmed the involvement of testicular hormone in the disease progression and enhanced cardiac remodelling in the LmnaH222P/H222P mice.
CONCLUSION: These observations indicated that nuclear accumulation of AR was associated with the gender difference in LMNA-linked DCM.

Entities:  

Keywords:  Androgen receptor; Dilated cardiomyopathy; Gender difference; Lamin A/C; Testosterone

Mesh:

Substances:

Year:  2013        PMID: 23631840     DOI: 10.1093/cvr/cvt106

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  18 in total

Review 1.  Molecular genetics and pathogenesis of cardiomyopathy.

Authors:  Akinori Kimura
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

2.  Nuclear lamina builds tissues from the stem cell niche.

Authors:  Haiyang Chen; Yixian Zheng
Journal:  Fly (Austin)       Date:  2014       Impact factor: 2.160

3.  Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival.

Authors:  Jason C Choi; Wei Wu; Elizabeth Phillips; Robin Plevin; Fusako Sera; Shunichi Homma; Howard J Worman
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

4.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878

Review 5.  Sex Differences in Aging: Genomic Instability.

Authors:  Kathleen E Fischer; Nicole C Riddle
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-01-16       Impact factor: 6.053

6.  Deficiency in ZMPSTE24 and resulting farnesyl-prelamin A accumulation only modestly affect mouse adipose tissue stores.

Authors:  Patrick J Heizer; Ye Yang; Yiping Tu; Paul H Kim; Natalie Y Chen; Yan Hu; Yuko Yoshinaga; Pieter J de Jong; Laurent Vergnes; Jazmin E Morales; Robert L Li; Nicholas Jackson; Karen Reue; Stephen G Young; Loren G Fong
Journal:  J Lipid Res       Date:  2020-01-15       Impact factor: 5.922

7.  Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation.

Authors:  Kenji Onoue; Hiroko Wakimoto; Jiangming Jiang; Michael Parfenov; Steven DePalma; David Conner; Joshua Gorham; David McKean; Jonathan G Seidman; Christine E Seidman; Yoshihiko Saito
Journal:  Front Cardiovasc Med       Date:  2021-06-23

8.  Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death.

Authors:  Michael V Zaragoza; Lianna Fung; Ember Jensen; Frances Oh; Katherine Cung; Linda A McCarthy; Christine K Tran; Van Hoang; Simin A Hakim; Anna Grosberg
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

9.  CAP2 in cardiac conduction, sudden cardiac death and eye development.

Authors:  Jeffrey Field; Diana Z Ye; Manasi Shinde; Fang Liu; Kurt J Schillinger; MinMin Lu; Tao Wang; Michelle Skettini; Yao Xiong; Angela K Brice; Daniel C Chung; Vickas V Patel
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

Review 10.  Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features.

Authors:  Lorenzo Maggi; Nicola Carboni; Pia Bernasconi
Journal:  Cells       Date:  2016-08-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.